Indefinite Delivery Contract SPE2DR25D3802

Award Date 3/24/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D1961 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as a primary vehicle for DLA to procure specialty...
The subject Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical...
The Indefinite Delivery Contract (IDC) SPE2DR25D1041 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC has a period of performance from August 1, 2025 to December 31, 2036, and supports DLA, the Department of Defense (DoD), the U.S. Coast Guard, and other government agencies by providing a comprehensive range of pharmaceutical products...
The Indefinite Delivery Contract (IDC) SPE2DR25D2208 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $999,999,999 contract has a performance period through December 2036 and serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D3013, awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 IDC has a period of performance through December 2026 and serves as a primary vehicle for the DLA to procure critical medical commodities, including specialty medications, brand-name...
The Indefinite Delivery Contract (IDC) SPE2DR25D3021 is a $9,999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for the DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish prime...
The Indefinite Delivery Contract (IDC) SPE2DB25D3002 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The single-award $999,999,999 contract, which runs through November 2026, provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, leverages its...
The indefinite delivery contract (IDC) SPE2DB25D3022 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at $999,999,999, covers the period from October 2024 through December 2026. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty...
The Indefinite Delivery Contract (IDC) SPE2DB25D3005 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. This single-award IDC has a ceiling value of $999,999,999.00 and a period of performance through November 30, 2026. Under this contract, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities...

The Indefinite Delivery Contract (IDC) SPE2DR25D3802 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract will have a 30-month base period and three 30-month option periods, running through December 2036. This IDC was competitively awarded as an unrestricted solicitation, with the intent to make multiple awards for separate regions to ensure resiliency in the Department of Defense's access to vital pharmaceuticals. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/29/25, 1:00 AM